HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Beatrice Schuler-Thurner Selected Research

Diphtheria Toxin

1/2014Immunogenic and tolerogenic effects of the chimeric IL-2-diphtheria toxin cytocidal agent Ontak® on CD25+ cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Beatrice Schuler-Thurner Research Topics

Disease

39Neoplasms (Cancer)
05/2024 - 05/2002
34Melanoma (Melanoma, Malignant)
03/2024 - 05/2002
6Uveal melanoma
05/2024 - 01/2017
6Neoplasm Metastasis (Metastasis)
07/2021 - 08/2004
3Infections
03/2024 - 12/2018
2Eosinophilia
03/2020 - 04/2017
2HIV Infections (HIV Infection)
01/2020 - 11/2002
2Lymphoma (Lymphomas)
08/2019 - 01/2018
2Disease Progression
01/2017 - 08/2004
1Squamous Cell Carcinoma of Head and Neck
03/2024
1Chondrosarcoma
03/2024
1Sclerosing Cholangitis
01/2023
1Hematologic Neoplasms (Hematological Malignancy)
01/2023
1Bites and Stings (Sting)
06/2021
1Leukemia
08/2019
1Skin Neoplasms (Skin Cancer)
01/2018
1Merkel Cell Carcinoma
07/2017
1Injection Site Reaction
04/2017
1Sarcoidosis (Schaumann Disease)
01/2017
1Inflammation (Inflammations)
01/2017
1Nevus (Nevi)
04/2014
1Optic Nerve Diseases (Optic Neuropathy)
04/2014
1Macular Degeneration (Age-Related Maculopathy)
04/2014
1Retinal Diseases
04/2014
1Hemangioma (Angioma)
04/2014
1Uveitis
04/2014
1Diabetic Retinopathy (Retinopathy, Diabetic)
04/2014
1Cushing Syndrome
04/2014
1Mydriasis
04/2014
1Cataract (Cataracts)
04/2014
1Pseudophakia
04/2014
1Arterial Occlusive Diseases (Arterial Occlusive Disease)
04/2014
1Central Serous Chorioretinopathy
04/2014
1Communicable Diseases (Infectious Diseases)
01/2010

Drug/Important Bio-Agent (IBA)

18AntigensIBA
05/2024 - 05/2002
12Peptides (Polypeptides)IBA
05/2024 - 05/2002
10VaccinesIBA
01/2023 - 04/2005
9Neoplasm Antigens (Tumor Antigens)IBA
01/2022 - 04/2003
7Messenger RNA (mRNA)IBA
01/2022 - 01/2005
6Chimeric Antigen ReceptorsIBA
01/2023 - 10/2014
5RNA (Ribonucleic Acid)IBA
01/2023 - 12/2015
5Proteins (Proteins, Gene)FDA Link
01/2018 - 05/2002
4Immune Checkpoint InhibitorsIBA
10/2023 - 03/2020
4Biomarkers (Surrogate Marker)IBA
01/2023 - 01/2017
4CytokinesIBA
05/2019 - 10/2014
3IpilimumabIBA
04/2017 - 01/2013
2talimogene laherparepvecIBA
03/2024 - 06/2021
2Indicators and Reagents (Reagents)IBA
01/2023 - 01/2017
2InterferonsIBA
06/2021 - 11/2002
2Cancer VaccinesIBA
03/2020 - 02/2011
2MART-1 AntigenIBA
01/2019 - 06/2005
2T-Cell Antigen Receptors (T-Cell Receptor)IBA
01/2019 - 08/2018
2HLA-A1 Antigen (HLA A1 Antigen)IBA
05/2008 - 11/2003
2Chondroitin Sulfate ProteoglycansIBA
04/2008 - 06/2007
2Monophenol Monooxygenase (Tyrosinase)IBA
06/2005 - 05/2005
2HLA-DPw4 antigenIBA
04/2005 - 01/2004
1HLA Antigens (Human Leukocyte Antigens)IBA
05/2024
1HMGB1 Protein (HMG1)IBA
03/2024
1Adenosine Triphosphate (ATP)IBA
03/2024
1cyclic guanosine monophosphate-adenosine monophosphateIBA
06/2021
1NectinsIBA
06/2021
1Surface Antigens (Surface Antigen)IBA
08/2018
1TNF-Related Apoptosis-Inducing LigandIBA
01/2018
1A-factor (Streptomyces)IBA
01/2018
1Small Interfering RNA (siRNA)IBA
01/2018
1Death Domain ReceptorsIBA
01/2018
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2018
1LigandsIBA
01/2018
1Phosphatidylethanolamine Binding ProteinIBA
09/2017
1raf KinasesIBA
09/2017
1Tumor Viral Antigens (Large T Antigen)IBA
07/2017
1Interleukin-6 (Interleukin 6)IBA
04/2017
1Dinoprostone (PGE2)FDA Link
04/2017
1Tumor Biomarkers (Tumor Markers)IBA
01/2017
1Transfer RNA (tRNA)IBA
12/2015
1HMW-MAAIBA
12/2015
1AutoantigensIBA
12/2014
1Monoclonal AntibodiesIBA
09/2014
1Retinaldehyde (Retinal)IBA
04/2014
1FibrinIBA
04/2014
1Dexamethasone (Maxidex)FDA LinkGeneric
04/2014
1iridalIBA
04/2014
1Interleukin-2 (IL2)IBA
01/2014
1Diphtheria ToxinIBA
01/2014
1Immunotoxins (Immunotoxin)IBA
04/2008
1Cyclosporine (Ciclosporin)FDA LinkGeneric
04/2008
1Immunoglobulin FragmentsIBA
04/2008
1ExotoxinsIBA
04/2008
1ChondroitinIBA
06/2007
1Membrane Glycoproteins (Membrane Glycoprotein)IBA
06/2007
1Proteoglycans (Proteoglycan)IBA
06/2007
1T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA
06/2007

Therapy/Procedure

20Immunotherapy
05/2024 - 10/2002
19Therapeutics
10/2023 - 08/2004
3Cell- and Tissue-Based Therapy (Cell Therapy)
01/2023 - 10/2014
2Blood Component Removal (Apheresis)
09/2003 - 10/2002
1Intralesional Injections
06/2021
1Drug Therapy (Chemotherapy)
01/2018
1Slit Lamp
04/2014
1Aftercare (After-Treatment)
04/2008